鞣花酸抗消化系统恶性肿瘤的作用机制

国际肿瘤学杂志››2016,Vol. 43››Issue (6): 472-474.doi:10.3760/cma.j.issn.1673-422X.2016.06.020

鞣花酸抗消化系统恶性肿瘤的作用机制

赵金璐，李国东，刘明

150001 哈尔滨医科大学第四临床医学院普外科，普外科生物样本库

收稿日期:2015-11-24出版日期:2016-06-08发布日期:2016-04-27
通讯作者:刘明 E-mail:mliu35@aliyun.com
基金资助:

国家自然科学基金（81372612、81302059）

Mechanism of anticarcinogenic function of ellagic acid in gastrointestinal cancers

Zhao Jinlu, Li Guodong, Liu Ming

Department of General Surgery, BioBank of Department of General Surgery, Fourth Clinical Medical College of Harbin Medical University, Harbin 150001, China

Received:2015-11-24Online:2016-06-08Published:2016-04-27
Contact:Liu Ming E-mail:mliu35@aliyun.com
Supported by:

National Natural Science Foundation of China (81372612, 81302059)

摘要/Abstract

摘要：体内、外实验均证实鞣花酸及其衍生代谢产物能抑制肿瘤细胞增殖、诱导凋亡、阻断DNA损伤诱发的癌变、阻断病毒感染、抑制炎症、抑制血管生成及抑制肿瘤细胞的耐药性等，对消化系统恶性肿瘤细胞生长起到抑制作用。鞣花酸及其衍生代谢产物可能成为抗肿瘤新药。

赵金璐，李国东，刘明. 鞣花酸抗消化系统恶性肿瘤的作用机制[J]. 国际肿瘤学杂志, 2016, 43(6): 472-474.

Zhao Jinlu, Li Guodong, Liu Ming. Mechanism of anticarcinogenic function of ellagic acid in gastrointestinal cancers[J]. Journal of International Oncology, 2016, 43(6): 472-474.

［1］刘新光. 消化系统恶性肿瘤的临床与研究［J］, 实用医院临床杂志, 2011, 8(1): 1-2. ［2］ Lee KW, Bode AM, Dong Z. Molecular targets of phytochemicals for cancer prevention［J］. Nat Rev Cancer, 2011, 11(3): 211-218. DOI: 10.1038/nrc3017. ［3］ NúezSnchez MA, GarcíaVillalba R, MonederoSaiz T, et al. Targeted metabolic profiling of pomegranate polyphenols and urolithins in plasma, urine and colon tissues from colorectal cancer patients［J］. 2014, 58(6): 1199-1211. DOI: 10.1002/mnfr.201300931. ［4］ Heber D. Multitargeted therapy of cancer by ellagitannins［J］. Cancer Lett, 2008, 269(2): 262-268. DOI: 10.1016/j. canlet. 2008.03.043. ［5］ Nambiar D, Rajamani P, Singh RP. Effects of phytochemicals on ionization radiationmediated carcinogenesis and cancer therapy［J］. Mutat Res, 2011, 728(3): 139-157. DOI: 10.1016/j.mrrev.2011.07.005. ［6］ Chen HS, Bai MH, Zhang T, et al. Ellagic acid induces cell cycle arrest and apoptosis through TGFβ/Smad3 signaling pathway in human breast cancer MCF7 cells［J］. Int J Oncol, 2015, 46(4): 1730-1738. DOI: 10.3892/ijo.2015.2870. ［7］ Anitha P, Priyadarsini RV, Kavitha K, et al. Ellagic acid coordinately attenuates Wnt/β-catenin and NFκB signaling pathways to induce intrinsic apoptosis in an animal model of oral oncogenesis［J］. Eur J Nutr, 2013, 52(1): 75-84. DOI: 10.1007/s00394-011-0288-y. ［8］ Weisburg JH, Schuck AG, Reiss SE, et al. Ellagic acid, a dietary polyphenol, selectively cytotoxic to HSC-2 oral carcinoma cells［J］. Anticancer Res, 2013, 33(5): 1829-1836. ［9］ Kowshik J, Giri H, Kishore TK, et al. Ellagic acid inhibits VEGF/VEGFR2, PI3K/Akt and MAPK signaling cascades in the hamster cheek pouch carcinogenesis model［J］. Anticancer Agents Med Chem, 2014, 14(9): 1249-1260. ［10］ Reen RK, Nines R, Stoner GD. Modulation of Nnitrosomethylbenzylamine metabolism by black raspberries in the esophagus and liver of Fischer 344 rats［J］. Nutr Cancer, 2006, 54(1): 47-57. DOI: 10.1207/s15327914nc5401_6. ［11］Zhao M, Tang SN, Marsh JL, et al. Ellagic acid inhibits human pancreatic cancer growth in Balb c nude mice［J］. Cancer Lett, 2013, 337(2): 210-217. DOI: 10.1016/j.canlet.2013.05.009. ［12］ Edderkaoui M, Lugea A, Hui H, et al. Ellagic acid and embelin affect key cellular components of pancreatic adenocarcinoma, cancer, and stellate cells［J］. Nutr Cancer, 2013, 65(8): 1232-1244. DOI: 10.1080/01635581.2013.832779. ［13］ Srigopalram S, Jayraaj IA, Kaleeswaran B, et al. Ellagic acid normalizes mitochondrial outer membrane permeabilization and attenuates inflammationmediated cell proliferation in experimental liver cancer［J］. Appl Biochem Biotechnol, 2014, 173(8): 2254-2266. DOI: 10.1007/s12010-014-1031-y. ［14］ Umesalma S, Nagendraprabhu P, Sudhandiran G. Ellagic acid inhibits proliferation and induced apoptosis via the Akt signaling pathway in HCT15 colon adenocarcinoma cells［J］. Mol Cell Biochem, 2015, 399(1/2): 303-313. DOI: 10.1007/s11010-014-2257-2. ［15］Umesalma S, Nagendraprabhu P, Sudhandiran G. Antiproliferative and apoptoticinducing potential of ellagic acid against 1,2dimethyl hydrazineinduced colon tumorigenesis in Wistar rats［J］. Mol Cell Biochem, 2014, 388(1/2): 157-172. DOI: 10.1007/s11010-013-1907-0. ［16］Umesalma S, Sudhandiran G. Ellagic acid prevents rat colon carcinogenesis induced by 1, 2 dimethyl hydrazine through inhibition of AKTphosphoinositide3 kinase pathway［J］. Eur J Pharmacol, 2011, 660(2/3): 249-258. DOI: 10.1016/j. ejphar. 2011. 03.036. ［17］Lea MA, Ibeh C, Han L, et al. Inhibition of growth and induction of differentiation markers by polyphenolic molecules and histone deacetylase inhibitors in colon cancer cells［J］. Anticancer Res, 2010, 30(2): 311-318. ［18］Marín M, María Giner R, Ríos JL, et al. Intestinal antiinflammatory activity of ellagic acid in the acute and chronic dextrane sulfate sodium models of mice colitis［J］. J Ethnopharmacol, 2013, 150(3): 925-934. DOI: 10.1016/j.jep.2013.09.030. ［19］NúezSánchez MA, GonzálezSarrías A, RomoVaquero M. Dietary phenolics against colorectal cancer—from promising preclinical results to poor translation into clinical trials: pitfalls and future needs［J］. Mol Nutr Food Res, 2015, 59(7): 1274-1291. DOI: 10.1002/mnfr.201400866. ［20］ GonzálezSarrías A, GiménezBastida JA, NúezSánchez M, et al. PhaseⅡ metabolism limits the antiproliferative activity of urolithins in human colon cancer cells［J］. Eur J Nutr, 2014, 53(3): 853-864. DOI: 10.1007/s00394-013-0589-4. ［21］GonzálezSarrías A, ToméCarneiro J, Bellesia A, et al. The ellagic acidderived gut microbiota metabolite, urolithin A, potentiates the anticancer effects of 5fluorouracil chemotherapy on human colon cancer cells［J］. Food Funct, 2015, 6(5): 1460-1469. DOI: 10.1039/c5fo00120j. ［22］Cho H, Jung H, Lee H, et al. Chemopreventive activity of ellagitannins and their derivatives from black raspberry seeds on HT-29 colon cancer cells［J］. 2015, 6(5): 1675-1683. DOI: 10.1039/c5fo00274e. ［23］Ramírez de Molina A, Vargas T, Molina S, et al. The ellagic acid derivative 4,4′diOmethylellagic acid efficiently inhibits colon cancer cell growth through a mechanism involving WNT16［J］. J Pharmacol Exp Ther, 2015, 353(2): 433-444. DOI: 10.1124/jpet.114.221796.

[1]	王丽薇, 梁洪生, 杜松林, 陈志豪, 王晴, 高爱丽.阿维菌素类药物在抗肿瘤方面的研究进展[J]. 国际肿瘤学杂志, 2022, 49(6): 353-356.
[2]	徐凯, 文刚, 李瑞, 田园.淋巴细胞与C反应蛋白比值对消化系统肿瘤预后价值的研究进展[J]. 国际肿瘤学杂志, 2022, 49(10): 627-629.
[3]	居欣月, 胡春梅, 赵月, 唐艳.CDX2与胃肠道肿瘤[J]. 国际肿瘤学杂志, 2021, 48(6): 374-376.
[4]	刘培培, 杨梦雪, 严雪冰.m⁶A甲基化修饰在消化系统肿瘤中的研究进展[J]. 国际肿瘤学杂志, 2021, 48(11): 688-692.
[5]	马英骥, 孙丽斌, 邱文生.长非编码RNA GHET1在消化系统肿瘤中的作用机制[J]. 国际肿瘤学杂志, 2020, 47(5): 304-307.
[6]	朱泽民, 谢智钦, 孙永康, 唐才喜.微小RNA-223与消化系统肿瘤[J]. 国际肿瘤学杂志, 2020, 47(2): 112-114.
[7]	齐瑞丽, 王华庆.血管靶向药物联合PD-1/PD-L1抗体在消化系统肿瘤治疗中的研究进展[J]. 国际肿瘤学杂志, 2019, 46(12): 750-754.
[8]	周帅阳，龚卫娟，肖炜明.血管生成素样蛋白4在消化系统肿瘤中的作用机制[J]. 国际肿瘤学杂志, 2018, 45(6): 371-374.
[9]	梁碧玉，何伟明，何小艺，丁元林，于海兵.糖尿病及降糖药物与胰腺癌[J]. 国际肿瘤学杂志, 2018, 45(3): 183-186.
[10]	石姗姗，周永宁，关泉林.长非编码RNA TUG1与消化系统肿瘤[J]. 国际肿瘤学杂志, 2018, 45(11): 688-691.
[11]	邱梅清, 王涛, 佟仲生, 贾勇圣.Mfn-2基因对人乳腺癌T47D细胞光动力疗法敏感性的影响及其作用机制[J]. 国际肿瘤学杂志, 2017, 44(8): 641-646.
[12]	张子瑾, 艾斌.免疫检查点阻断剂治疗消化系统肿瘤研究进展[J]. 国际肿瘤学杂志, 2017, 44(1): 63-66.
[13]	潘磊, 梁炜, 付敏, 钱晖, 许文荣, 蒋鹏程, 张徐.长非编码RNA在消化系统肿瘤中的研究进展[J]. 国际肿瘤学杂志, 2016, 43(8): 706-710.
[14]	王艳俊,蒋永新,刘珊,王红,葛吕.青蒿素及其衍生物对肿瘤的放疗增敏作用[J]. 国际肿瘤学杂志, 2016, 43(8): 612-614.
[15]	熊婷,李丽丁,严欣,谢飞燕,廖彩勤 ,陆凯强,刘晓旺,涂剑.染料木素在恶性肿瘤发生发展中的作用机制[J]. 国际肿瘤学杂志, 2016, 43(8): 609-611.